| Dr Careen-joan Franklin, PHARMD | |
|
2300 4th St Nw, Washington, DC 20059-1009 | |
| (202) 806-3126 | |
| Not Available |
| Full Name | Dr Careen-joan Franklin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2300 4th St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205564887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202221328 (Virginia) | Secondary |
| 183500000X | Pharmacist | PH100004095 (District Of Columbia) | Primary |
| 183500000X | Pharmacist | 25883 (Maryland) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Careen-joan Franklin, PHARMD 2300 N Pershing Dr Ste 201, Arlington, VA 22201-1428 Ph: (571) 257-7797 | Dr Careen-joan Franklin, PHARMD 2300 4th St Nw, Washington, DC 20059-1009 Ph: (202) 806-3126 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that patent infringement litigation pertaining to Teva's generic version of sanofi-aventis and Debiopharm's Eloxatin (oxaliplatin injection) has been dismissed by the United States District Court for the District of New Jersey pursuant to a settlement between the parties.
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
A new study, published in The Journal of Clinical Investigation, describes an effective model of a rare form of the disease called transient neonatal diabetes mellitus (TNDM), which affects approximately 1 in 600,000 newborn babies.
An international team of scientists led by researchers at The Scripps Research Institute has developed a straightforward technique to determine the ethnic origin of stem cells.
› Verified 4 days ago
Juliana O Anamelechi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000 | |
Reine Kamtcheu Lienou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 | |
Gina Jin Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-4080 | |
Dr. Bruce Cofane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 845 Bladensburg Rd Ne, Washington, DC 20002 Phone: 202-397-2600 | |
Mesay Abebe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 14th St Nw, Washington, DC 20010 Phone: 202-777-3774 | |
Dr. Salome K Bwayo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 4th St Nw, Washington, DC 20059 Phone: 202-806-7262 Fax: 202-806-4478 | |
Tracy Doney, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Rm B147, Washington, DC 20010 Phone: 202-877-6747 |